Why are clinical trials of glucosamine no longer uniformly positive?
- 30 November 2003
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 29 (4) , 789-801
- https://doi.org/10.1016/s0889-857x(03)00064-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Glucosamine Sulfate Use and Delay of Progression of Knee OsteoarthritisArchives of internal medicine (1960), 2002
- A randomized, double‐blind, placebo‐controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the kneeRheumatology, 2002
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trialThe Lancet, 2001
- Glucosamine and Chondroitin for Treatment of OsteoarthritisJAMA, 2000
- Randomized, controlled trial of glucosamine for treating osteoarthritis of the kneeWestern Journal of Medicine, 2000
- Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklistsControlled Clinical Trials, 1995
- The neglect of glucosamine as a treatment for osteoarthritis — A personal perspectiveMedical Hypotheses, 1994
- Glucosamine sulfate in osteoarthritis of the kneeOsteoarthritis and Cartilage, 1994
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981
- Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosisCurrent Medical Research and Opinion, 1980